Founded with a mission to combat the devastating impact of citrus diseases, Soilcea leverages CRISPR precision breeding technology to develop disease-resistant citrus trees. The company focuses on addressing critical issues like Huanglongbing (citrus greening disease) and citrus canker, which have significantly harmed the citrus industry, particularly in Florida. By utilizing exclusive licenses to patents from community universities, Soilcea aims to restore and sustain citrus production through innovative genetic solutions.
Soilcea's notable affiliations include partnerships with leading academic institutions that provide the foundational patents for their CRISPR technology. The company has achieved significant milestones, such as developing CRISPR-edited trees that show resistance to the most destructive citrus diseases. This breakthrough has the potential to save millions of trees and billions in revenue, marking a substantial impact on the agricultural sector and offering a promising future for sustainable citrus farming.